Multivalent protein polymer mri contrast agents: Controlling relaxivity via modulation of amino acid sequence

Lindsay S. Karfeld-Sulzer, Emily A. Waters, Nicolynn E. Davis, Thomas J. Meade, Annelise E. Barron

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Magnetic resonance imaging is a noninvasive imaging modality with high spatial and temporal resolution. Contrast agents (CAs) are frequently used to increase the contrast between tissues of interest. To increase the effectiveness of MR agents, small molecule CAs have been attached to macromolecules. We have created a family of biodegradable, macromolecular CAs based on protein polymers, allowing control over the CA properties. The protein polymers are monodisperse, random coil, and contain evenly spaced lysines that serve as reactive sites for Gd(III) chelates. The exact sequence and length of the protein can be specified, enabling controlled variation in lysine spacing and molecular weight. Relaxivity could be modulated by changing protein polymer length and lysine spacing. Relaxivities of up to ∼14 mM-1 s-1 per Gd(III) and ∼461 mM-1 s-1 per conjugate were observed. These CAs are biodegradable by incubation with plasmin, such that they can be easily excreted after use. They do not reduce cell viability, a prerequisite for future in vivo studies. The protein polymer CAs can be customized for different clinical diagnostic applications, including biomaterial tracking, as a balanced agent with high relaxivity and appropriate molar mass.

Original languageEnglish (US)
Pages (from-to)1429-1436
Number of pages8
JournalBiomacromolecules
Volume11
Issue number6
DOIs
StatePublished - Jul 14 2010

ASJC Scopus subject areas

  • Bioengineering
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

Fingerprint Dive into the research topics of 'Multivalent protein polymer mri contrast agents: Controlling relaxivity via modulation of amino acid sequence'. Together they form a unique fingerprint.

  • Cite this